While AVITA Medical Inc has underperformed by -1.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RCEL fell by -57.27%, with highs and lows ranging from $14.16 to $3.60, whereas the simple moving average fell by -30.54% in the last 200 days.
On August 08, 2025, BTIG Research Downgraded AVITA Medical Inc (NASDAQ: RCEL) to Sell. A report published by D. Boral Capital on December 24, 2024, Initiated its previous ‘Buy’ rating for RCEL. Cantor Fitzgerald Initiated an Overweight rating on June 27, 2023, and assigned a price target of $23. Piper Sandler initiated its ‘Overweight’ rating for RCEL, as published in its report on March 02, 2021. BofA Securities’s report from August 27, 2020 suggests a price prediction of $42 for RCEL shares, giving the stock a ‘Buy’ rating. Oppenheimer also rated the stock as ‘Outperform’.
Analysis of AVITA Medical Inc (RCEL)
Further, the quarter-over-quarter increase in sales is 21.21%, showing a positive trend in the upcoming months.
One of the most important indicators of AVITA Medical Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -935.73% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.46, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and RCEL is recording 656.61K average volume. On a monthly basis, the volatility of the stock is set at 7.29%, whereas on a weekly basis, it is put at 12.56%, with a gain of 19.96% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.43, showing growth from the present price of $5.47, which can serve as yet another indication of whether RCEL is worth investing in or should be passed over.
How Do You Analyze AVITA Medical Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.31%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 31.11% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
